Unlocking Hope for Cancer Patients Using PDT
ADDRESSING ASIAN-CENTRIC DISEASES
ADDRESSING A GLOBALLY RELEVANT UNMET NEED
15
Asians comprise 6% of clinical trial patients in FDA approved drugs²
... yet 60% of the world is Asian
UNDER-REPRESENTATION IN
DRUG DEVELOPMENT
Ethnic Breakdown of Clinical Trials for 2020
Approved Drugs²
11% Hispanic
8% Black
6% Asian
MISMATCH WITH GLOBAL INCIDENCE
Nasopharyngeal Cancer
86.0% cases in Asia, esp.
China, HK
Oral Cancer
65.8%¹ cases in Asia
esp. India, Indonesia,
Pakistan
Stomach Cancer
75.3% cases in Asia, esp.
Korea, Japan and China
Oesophageal Cancer
79.7% cases in Asia esp.
in east Asians
75% White
Liver Cancer
72.5% cases in Asia mainly
in China
Non-Smoker Lung Cancer
60-80% women in Asia with lung cancer are
non-smokers (esp. China). Highest among
Asian American females in US4
Thfps://gco.jarc.fr/today/fact-sheets-cancers. GLOBOCON 2020
2 Source: Food and Drug Administration - 2020 Drug Trials Snapshots Summary
3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431055/#b12-ms117_p0375
4 https://med.stanford.edu/content/dam/sm/care/communityheathtalk/Stanford-Community-Health-Talk-LCINF-
FANS-2-21-2022.pdf
INVIONView entire presentation